Lv5
876 积分 2025-07-10 加入
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
1个月前
已完结
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
1个月前
已完结
Metastatic Breast Carcinoma to the Bladder
5个月前
已完结
[Chinese expert consensus on D-dimer laboratory testing and clinical application]
6个月前
已完结
早期胃癌内镜治疗与适应证扩展的研究进展
7个月前
已完结
Review: Gastric malignancies: Basic aspects
7个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
7个月前
已完结
The next generation of immunotherapies for lung cancers
7个月前
已完结
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
7个月前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
7个月前
已完结
皖公网安备34019202002308
